{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:29:09Z","timestamp":1789576149971,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Delta-9-tetrahydrocannabinol (THC) is known to modulate immune response in peripheral\u00a0blood cells. The mechanisms of THC\u2019s effects on gene expression in human immune cells remains poorly understood. Combining a within-subject design with single cell transcriptome mapping, we report that THC acutely alters gene expression in 15,973 blood cells. We identified 294 transcriptome-wide significant genes among eight cell types including 69 common genes and 225 cell-type-specific genes affected by THC administration, including those genes involving in immune response, cytokine production, cell proliferation and apoptosis. We revealed distinct transcriptomic sub-clusters affected by THC in major immune cell types where THC perturbed cell-type-specific intracellular gene expression correlations. Gene set enrichment analysis further supports the findings of THC\u2019s common and cell-type-specific effects on immune response and cell toxicity. This comprehensive single-cell transcriptomic profiling provides important insights into THC\u2019s acute effects on immune function that may have important medical implications.<\/jats:p>","DOI":"10.1038\/s41598-020-59827-1","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T06:03:14Z","timestamp":1582696994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans"],"prefix":"10.1038","volume":"10","author":[{"given":"Ying","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-5102","authenticated-orcid":false,"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-2441","authenticated-orcid":false,"given":"Xiaoyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awo","family":"Osafo-Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-9334","authenticated-orcid":false,"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Aouizerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak C.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"59827_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41584-018-0025-5","volume":"14","author":"D Katz-Talmor","year":"2018","unstructured":"Katz-Talmor, D., Katz, I., Porat-Katz, B. S. & Shoenfeld, Y. Cannabinoids for the treatment of rheumatic diseases - where do we stand? Nat. Rev. Rheumatol. 14, 488\u2013498 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"59827_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","volume":"36","author":"M Maccarrone","year":"2015","unstructured":"Maccarrone, M. et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 36, 277\u201396 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"59827_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","volume":"215","author":"R Tanasescu","year":"2010","unstructured":"Tanasescu, R. & Constantinescu, C. S. Cannabinoids and the immune system: an overview. Immunobiology 215, 588\u201397 (2010).","journal-title":"Immunobiology"},{"key":"59827_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","volume":"46","author":"K Mackie","year":"2006","unstructured":"Mackie, K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 46, 101\u201322 (2006).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"59827_CR5","doi-asserted-by":"publisher","first-page":"13175","DOI":"10.1074\/jbc.271.22.13175","volume":"271","author":"R Condie","year":"1996","unstructured":"Condie, R., Herring, A., Koh, W. S., Lee, M. & Kaminski, N. E. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J. Biol. Chem. 271, 13175\u201383 (1996).","journal-title":"J. Biol. Chem."},{"key":"59827_CR6","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","volume":"73","author":"C Turcotte","year":"2016","unstructured":"Turcotte, C., Blanchet, M. R., Laviolette, M. & Flamand, N. The CB2 receptor and its role as a regulator of inflammation. Cell Mol. Life Sci. 73, 4449\u20134470 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"59827_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/243407a0","volume":"243","author":"GG Nahas","year":"1973","unstructured":"Nahas, G. G., Zagury, D., Schwartz, I. W. & Nagel, M. D. Evidence for the possible immunogenicity of delta 9-tetrahydrocannabinol (THC) in rodents. Nat. 243, 407\u20138 (1973).","journal-title":"Nat."},{"key":"59827_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","volume":"166","author":"JL Croxford","year":"2005","unstructured":"Croxford, J. L. & Yamamura, T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J. Neuroimmunol. 166, 3\u201318 (2005).","journal-title":"J. Neuroimmunol."},{"key":"59827_CR9","first-page":"1748","volume":"36","author":"GG Nahas","year":"1977","unstructured":"Nahas, G. G., Morishima, A. & Desoize, B. Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed. Proc. 36, 1748\u201352 (1977).","journal-title":"Fed. Proc."},{"key":"59827_CR10","doi-asserted-by":"publisher","first-page":"15460","DOI":"10.1074\/jbc.M116.719179","volume":"291","author":"X Yang","year":"2016","unstructured":"Yang, X., Bam, M., Nagarkatti, P. S. & Nagarkatti, M. RNA-seq Analysis of delta9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation. J. Biol. Chem. 291, 15460\u201372 (2016).","journal-title":"J. Biol. Chem."},{"key":"59827_CR11","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","volume":"174","author":"RJ McKallip","year":"2005","unstructured":"McKallip, R. J., Nagarkatti, M. & Nagarkatti, P. S. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 174, 3281\u20139 (2005).","journal-title":"J. Immunol."},{"key":"59827_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","volume":"133","author":"M Yuan","year":"2002","unstructured":"Yuan, M. et al. Delta 9-Tetrahydrocannabinol regulates Th1\/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133, 124\u201331 (2002).","journal-title":"J. Neuroimmunol."},{"key":"59827_CR13","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","volume":"312","author":"B Herrera","year":"2006","unstructured":"Herrera, B. et al. The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp. Cell Res. 312, 2121\u201331 (2006).","journal-title":"Exp. Cell Res."},{"key":"59827_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1541-7786.MCR-05-0193","volume":"4","author":"W Jia","year":"2006","unstructured":"Jia, W. et al. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol. Cancer Res. 4, 549\u201362 (2006).","journal-title":"Mol. Cancer Res."},{"key":"59827_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature12172","volume":"498","author":"AK Shalek","year":"2013","unstructured":"Shalek, A. K. et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nat. 498, 236\u201340 (2013).","journal-title":"Nat."},{"key":"59827_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nbt.2642","volume":"31","author":"QF Wills","year":"2013","unstructured":"Wills, Q. F. et al. Single-cell gene expression analysis reveals genetic associations masked in whole-tissue experiments. Nat. Biotechnol. 31, 748\u201352 (2013).","journal-title":"Nat. Biotechnol."},{"key":"59827_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.aan6828","volume":"358","author":"MJT Stubbington","year":"2017","unstructured":"Stubbington, M. J. T., Rozenblatt-Rosen, O., Regev, A. & Teichmann, S. A. Single-cell transcriptomics to explore the immune system in health and disease. Sci. 358, 58\u201363 (2017).","journal-title":"Sci."},{"key":"59827_CR18","doi-asserted-by":"crossref","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature (2019).","DOI":"10.1038\/s41586-019-1195-2"},{"key":"59827_CR19","doi-asserted-by":"crossref","unstructured":"Cahill, J. D. Psychotomimetic and Cognitive Effects of \u03949-Tetrahydrocannabinol in Laboratory Settings. The Complex Connection Between Cannabis and Schizophrenia, 75\u2013128 (2018).","DOI":"10.1016\/B978-0-12-804791-0.00004-5"},{"key":"59827_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D\u2019Souza","year":"2004","unstructured":"D\u2019Souza, D. C. et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558\u201372 (2004).","journal-title":"Neuropsychopharmacology"},{"key":"59827_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/clpt.1980.181","volume":"18","author":"A Ohlsson","year":"1980","unstructured":"Ohlsson, A. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharmacology Therapeutics 18, 409\u201316 (1980).","journal-title":"Clin. Pharmacology Therapeutics"},{"key":"59827_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/clpt.1983.179","volume":"34","author":"ME Wall","year":"1983","unstructured":"Wall, M. E., Sadler, B. M., Brine, D., Taylor, H. & Perez-Reyes, M. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. 34, 352\u201363 (1983).","journal-title":"Clin. Pharmacol. Ther."},{"key":"59827_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D\u2019Souza","year":"2004","unstructured":"D\u2019Souza, D. C. et al. The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. Neuropsychopharmacology 29, 1558 (2004).","journal-title":"Neuropsychopharmacology"},{"key":"59827_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00213-011-2417-y","volume":"219","author":"M Carbuto","year":"2012","unstructured":"Carbuto, M. et al. The safety of studies with intravenous Delta(9)-tetrahydrocannabinol in humans, with case histories. Psychopharmacol. 219, 885\u201396 (2012).","journal-title":"Psychopharmacol."},{"key":"59827_CR25","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/0269881118799953","volume":"32","author":"DL Boggs","year":"2018","unstructured":"Boggs, D. L. et al. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Delta(9)-THC) in humans. J. Psychopharmacol. 32, 1308\u20131318 (2018).","journal-title":"J. Psychopharmacol."},{"key":"59827_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopsych.2016.01.011","volume":"79","author":"M Sherif","year":"2016","unstructured":"Sherif, M., Radhakrishnan, R., D\u2019Souza, D. C. & Ranganathan, M. Human Laboratory Studies on Cannabinoids and Psychosis. Biol. Psychiatry 79, 526\u201338 (2016).","journal-title":"Biol. Psychiatry"},{"key":"59827_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"59827_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411 (2018).","journal-title":"Nat. Biotechnol."},{"key":"59827_CR29","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724\u201335 (2007).","journal-title":"PLoS Genet."},{"key":"59827_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02289-3","volume":"8","author":"M Schelker","year":"2017","unstructured":"Schelker, M. et al. Estimation of immune cell content in tumour tissue using single-cell RNA-seq data. Nat. Commun. 8, 2032 (2017).","journal-title":"Nat. Commun."},{"key":"59827_CR31","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","volume":"72","author":"C Gebhardt","year":"2006","unstructured":"Gebhardt, C., Nemeth, J., Angel, P. & Hess, J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622\u201331 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"59827_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2567.2012.03619.x","volume":"137","author":"M Riva","year":"2012","unstructured":"Riva, M. et al. Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent. Immunology 137, 172\u201382 (2012).","journal-title":"Immunology"},{"key":"59827_CR33","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.1074\/jbc.M806605200","volume":"284","author":"C Champaiboon","year":"2009","unstructured":"Champaiboon, C., Sappington, K. J., Guenther, B. D., Ross, K. F. & Herzberg, M. C. Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte resistance to bacterial invasion. J. Biol. Chem. 284, 7078\u201390 (2009).","journal-title":"J. Biol. Chem."},{"key":"59827_CR34","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood-2010-03-273953","volume":"116","author":"P Tewary","year":"2010","unstructured":"Tewary, P. et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 116, 3465\u201374 (2010).","journal-title":"Blood"},{"key":"59827_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1191\/0960327104ht426oa","volume":"23","author":"M El-Gohary","year":"2004","unstructured":"El-Gohary, M. & Eid, M. A. Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students. Hum. Exp. Toxicol. 23, 149\u201356 (2004).","journal-title":"Hum. Exp. Toxicol."},{"key":"59827_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2007.06.001","volume":"189","author":"TK Eisenstein","year":"2007","unstructured":"Eisenstein, T. K., Meissler, J. J., Wilson, Q., Gaughan, J. P. & Adler, M. W. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. J. Neuroimmunol. 189, 17\u201322 (2007).","journal-title":"J. Neuroimmunol."},{"key":"59827_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1124\/jpet.106.108381","volume":"319","author":"T Lu","year":"2006","unstructured":"Lu, T., Newton, C., Perkins, I., Friedman, H. & Klein, T. W. Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J. Pharmacol. Exp. Ther. 319, 269\u201376 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"59827_CR38","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.2174\/138161206777947425","volume":"12","author":"P Massi","year":"2006","unstructured":"Massi, P., Vaccani, A. & Parolaro, D. Cannabinoids, immune system and cytokine network. Curr. Pharm. Des. 12, 3135\u201346 (2006).","journal-title":"Curr. Pharm. Des."},{"key":"59827_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jcp.21919","volume":"222","author":"GS Winkler","year":"2010","unstructured":"Winkler, G. S. The mammalian anti-proliferative BTG\/Tob protein family. J. Cell Physiol. 222, 66\u201372 (2010).","journal-title":"J. Cell Physiol."},{"key":"59827_CR40","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1128\/MCB.25.14.5834-5845.2005","volume":"25","author":"A Sofer","year":"2005","unstructured":"Sofer, A., Lei, K., Johannessen, C. M. & Ellisen, L. W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell Biol. 25, 5834\u201345 (2005).","journal-title":"Mol. Cell Biol."},{"key":"59827_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0785-2","volume":"19","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer. Breast Cancer Res. 19, 15 (2017).","journal-title":"Breast Cancer Res."},{"key":"59827_CR42","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1093\/nar\/gkg899","volume":"31","author":"A Tabb-Massey","year":"2003","unstructured":"Tabb-Massey, A. et al. Ribosomal proteins Rps0 and Rps21 of Saccharomyces cerevisiae have overlapping functions in the maturation of the 3\u2032 end of 18S rRNA. Nucleic Acids Res. 31, 6798\u2013805 (2003).","journal-title":"Nucleic Acids Res."},{"key":"59827_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.2918","volume":"225","author":"A Wang","year":"2011","unstructured":"Wang, A. et al. Ribosomal protein RPL41 induces rapid degradation of ATF4, a transcription factor critical for tumour cell survival in stress. J. Pathol. 225, 285\u201392 (2011).","journal-title":"J. Pathol."},{"key":"59827_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"59827_CR45","first-page":"1334","volume":"270","author":"W Zhu","year":"1994","unstructured":"Zhu, W., Newton, C., Daaka, Y., Friedman, H. & Klein, T. W. delta 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther. 270, 1334\u20139 (1994).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"59827_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1006\/geno.1995.9878","volume":"30","author":"W Albig","year":"1995","unstructured":"Albig, W. et al. The human replacement histone H3.3B gene (H3F3B). Genomics 30, 264\u201372 (1995).","journal-title":"Genomics"},{"key":"59827_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1073\/pnas.1814027116","volume":"116","author":"C Li","year":"2019","unstructured":"Li, C. et al. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proc. Natl Acad. Sci. USA 116, 619\u2013624 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59827_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05782-5","volume":"9","author":"DH Kim","year":"2018","unstructured":"Kim, D. H. et al. Intracellular interleukin-32gamma mediates antiviral activity of cytokines against hepatitis B virus. Nat. Commun. 9, 3284 (2018).","journal-title":"Nat. Commun."},{"key":"59827_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","volume":"3","author":"A Yoshimura","year":"2012","unstructured":"Yoshimura, A., Suzuki, M., Sakaguchi, R., Hanada, T. & Yasukawa, H. SOCS, Inflammation, and Autoimmunity. Front. Immunol. 3, 20 (2012).","journal-title":"Front. Immunol."},{"key":"59827_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(99)00262-0","volume":"237","author":"Y Mamane","year":"1999","unstructured":"Mamane, Y. et al. Interferon regulatory factors: the next generation. Gene 237, 1\u201314 (1999).","journal-title":"Gene"},{"key":"59827_CR51","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/j.1460-2075.1993.tb05831.x","volume":"12","author":"T Shirasawa","year":"1993","unstructured":"Shirasawa, T. et al. A novel gene product associated with mu chains in immature B cells. EMBO J. 12, 1827\u201334 (1993).","journal-title":"EMBO J."},{"key":"59827_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0143-4160(98)90028-8","volume":"23","author":"SL Toutenhoofd","year":"1998","unstructured":"Toutenhoofd, S. L. et al. Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3. Cell Calcium 23, 323\u201338 (1998).","journal-title":"Cell Calcium"},{"key":"59827_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni1198","volume":"6","author":"S Divanovic","year":"2005","unstructured":"Divanovic, S. et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6, 571\u20138 (2005).","journal-title":"Nat. Immunol."},{"key":"59827_CR54","doi-asserted-by":"publisher","first-page":"13667","DOI":"10.1074\/jbc.M113.540799","volume":"289","author":"S Shah","year":"2014","unstructured":"Shah, S., King, E. M., Chandrasekhar, A. & Newton, R. Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone. J. Biol. Chem. 289, 13667\u201379 (2014).","journal-title":"J. Biol. Chem."},{"key":"59827_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-2999(01)01122-0","volume":"423","author":"SF Lee","year":"2001","unstructured":"Lee, S. F., Newton, C., Widen, R., Friedman, H. & Klein, T. W. Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur. J. Pharmacol. 423, 235\u201341 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"59827_CR56","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","volume":"105","author":"JE Lauckner","year":"2008","unstructured":"Lauckner, J. E. et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl Acad. Sci. USA 105, 2699\u2013704 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59827_CR57","doi-asserted-by":"publisher","first-page":"18707","DOI":"10.1074\/jbc.M113.545210","volume":"289","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. Histone modifications are associated with Delta9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. J. Biol. Chem. 289, 18707\u201318 (2014).","journal-title":"J. Biol. Chem."},{"key":"59827_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/00004583-199009000-00003","volume":"29","author":"RL Spitzer","year":"1990","unstructured":"Spitzer, R. L., Davies, M. & Barkley, R. A. The DSM-III-R field trial of disruptive behavior disorders. J. Am. Acad. Child. Adolesc. Psychiatry 29, 690\u20137 (1990).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"59827_CR59","first-page":"21","volume":"38","author":"S Agurell","year":"1986","unstructured":"Agurell, S. et al. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev. 38, 21\u201343 (1986).","journal-title":"Pharmacol. Rev."},{"key":"59827_CR60","first-page":"47","volume":"105","author":"ND Volkow","year":"1990","unstructured":"Volkow, N. D., Fowler, J. S., Wolf, A. P. & Gillespi, H. Metabolic studies of drugs of abuse. NIDA Res. Monogr. 105, 47\u201353 (1990).","journal-title":"NIDA Res. Monogr."},{"key":"59827_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0925-4927(96)02817-X","volume":"67","author":"ND Volkow","year":"1996","unstructured":"Volkow, N. D. et al. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res. 67, 29\u201338 (1996).","journal-title":"Psychiatry Res."},{"key":"59827_CR62","first-page":"114","volume":"261","author":"JL Azorlosa","year":"1992","unstructured":"Azorlosa, J. L., Heishman, S. J., Stitzer, M. L. & Mahaffey, J. M. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J. Pharmacol. Exp. Ther. 261, 114\u201322 (1992).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"59827_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang, D. W. et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8, R183 (2007).","journal-title":"Genome Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59827-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:29:47Z","timestamp":1670293787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59827-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59827"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59827-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/638254","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All co-authors except Dr. Krystal declare no completing interests. The following competing interests for John H. Krystal: RE: John H. Krystal, MD 2019 Financial Disclosure.ConsultantNote: \u2013 The Individual Consultant Agreements listed below are less than $10,000 per yearAstraZeneca PharmaceuticalsBiogen, Idec, MABiomedisyn CorporationBionomics, Limited (Australia)Boehringer Ingelheim InternationalConcert Pharmaceuticals, Inc.Epiodyne, Inc.Heptares Therapeutics, Limited (UK)Janssen Research & DevelopmentL.E.K. ConsultingOtsuka America Pharmaceutical, Inc.Perception Neuroscience Holdings, Inc.Spring Care, Inc.Sunovion Pharmaceuticals, Inc.Takeda IndustriesTaisho Pharmaceutical Co., Ltd<u>Scientific Advisory Board<\/u>Bioasis Technologies, Inc.Biohaven PharmaceuticalsBioXcel Therapeutics, Inc. (Clinical Advisory Board)Cadent Therapeutics (Clinical Advisory Board)PsychoGenics, Inc.Stanley Center for Psychiatric research at the Broad Institute of MIT and HarvardLohocla Research Corporation<u>Stock<\/u>ArRETT Neuroscience, Inc.Biohaven PharmaceuticalsSage PharmaceuticalsSpring Care, Inc.<u>Stock Options<\/u>Biohaven Pharmaceuticals Medical SciencesBlackThorn Therapeutics, Inc.Storm Biosciences, Inc.<u>Income Greater than $10,000<\/u><u>Editorial Board<\/u>Editor - Biological Psychiatry<u>Patents and Inventions<\/u>1) Seibyl JP, Krystal JH, Charney DS. Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia. US Patent #:5,447,948.September 5, 19952) Vladimir, Coric, Krystal, John H, Sanacora, Gerard \u2013 Glutamate Modulating Agents in the Treatment of Mental Disorders US Patent No. 8,778,979 B2 Patent Issue Date: July 15, 2014. US Patent Application No. 15\/695,164: Filing Date: 09\/05\/20173) Charney D, Krystal JH, Manji H, Matthew S, Zarate C., - Intranasal Administration of Ketamine to Treat Depression United States Application No. 14\/197,767 filed on March 5, 2014; United States application or Patent Cooperation Treaty (PCT) International application No. 14\/306,382 filed on June 17, 20144) Zarate, C, Charney, DS, Manji, HK, Mathew, Sanjay J, Krystal, JH, Department of Veterans Affairs \u201cMethods for Treating Suicidal Ideation\u201d, Patent Application No. 14\/197.767 filed on March 5, 2014 by Yale University Office of Cooperative Research5) Arias A, Petrakis I, Krystal JH. \u2013 Composition and methods to treat addiction.Provisional Use Patent Application no.61\/973\/961. April 2, 2014. Filed by Yale University Office of Cooperative Research.6) Chekroud, A., Gueorguieva, R., & Krystal, JH. \u201cTreatment Selection for Major Depressive Disorder\u201d [filing date 3rd June 2016, USPTO docket number Y0087.70116US00]. Provisional patent submission by Yale University7) Gihyun, Yoon, Petrakis I, Krystal JH \u2013 Compounds, Compositions and Methods for Treating or Preventing Depression and Other Diseases. U. S. Provisional Patent Application No. 62\/444,552, filed on January10, 2017 by Yale University Office of Cooperative Research OCR 7088 US018) Abdallah, C, Krystal, JH, Duman, R, Sanacora, G. Combination Therapy for Treating or Preventing Depression or Other Mood Diseases. U.S. Provisional Patent Application No. 047162-7177P1 (00754) filed on August 20, 2018 by Yale University Office of Cooperative Research OCR 7451 US01<u>NON-Federal Research Support<\/u>AstraZeneca Pharmaceuticals provides the drug, Saracatinib, for research related to NIAAA grant \u201cCenter for Translational Neuroscience of Alcoholism [CTNA-4].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3450"}}